Trials / Sponsors / Scancell Ltd
Scancell Ltd
Industry · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer Triple Negative Breast Cancer, Renal Cell Cancer, High Grade Ovarian Serous Adenocarcinoma | Phase 1 / Phase 2 | 2022-04-07 |
| Unknown | A First Time in Human Phase 1 Open-Label Study of the COVIDITY Vaccine Administered by Needle-free Injection COVID-19 | Phase 1 | 2021-10-01 |
| Active Not Recruiting | SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SC Malignant Melanoma, Melanoma (Skin), Melanoma Stage III | Phase 2 | 2019-08-19 |
| Terminated | Study of a DNA Immunotherapy to Treat Melanoma Malignant Melanoma | Phase 1 / Phase 2 | 2010-05-01 |